BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

TONIX PHARMACEUTICALS — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

TONIX PHARMACEUTICALS

via THE SHELBURNE GROUP

4th Quarter (Oct 1 - Dec 31) · 2021Posted Jan 17, 2022Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: TONIX PHARMACEUTICALS
Description: Pharmaceutical company
Location: New York · United States of America

Registrant

Firm: THE SHELBURNE GROUP
Description: Lobbying Firm
Location: Fairfield, Connecticut, United States of America

Lobbying activities

1 issue

Health Issues
Issues regarding military-related PTSD
LobbyistsGREG MEISELBACH
TargetedSENATE · HOUSE OF REPRESENTATIVES · Veterans Affairs, Dept of (VA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.